Literature DB >> 6329769

Protective effect of oral oxyphenonium bromide, terbutaline and theophylline against the bronchial obstructive effects of inhaled histamine, acetylcholine and propranolol.

G H Koëter, H Meurs, J H Jonkman, J Greving, J Leferink, H J Sluiter, R A de Zeeuw, K de Vries.   

Abstract

The protective effects of oxyphenonium bromide, terbutaline and theophylline were compared in 8 asthmatic patients by determination of the degree of non-specific airway reactivity after 1 week of oral treatment according to a fixed dose scheme in a double-blind random order: oxyphenonium bromide 3 X 10 mg; terbutaline 3 X 5 mg; theophylline 2 X 300 mg and placebo. Controlled, standardized inhalation provocation tests were carried out with histamine, acetylcholine and propranolol. The study was monitored by measuring blood concentrations of the 3 drugs, and their effect on the plasma cAMP concentration was also determined. Significant protection by oxyphenonium bromide against the bronchial obstructive effects of acetylcholine and propranolol was observed, but not against the effect of inhaled histamine. The other two drugs provided no significant protection against the inhaled agents. The absence of any protective effect of terbutaline and theophylline might have resulted from too low a blood concentration. The observed differences in protection could not be explained by changes in pulmonary function. The study suggests dissociation between the bronchodilating effect of a drug and its protective effect against inhaled substances.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6329769     DOI: 10.1007/bf00542137

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  25 in total

1.  Protective effect of drugs on histamine-induced asthma.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Thorax       Date:  1977-08       Impact factor: 9.139

2.  Interaction between isoprenaline and aminophylline in asthma.

Authors:  I A Campbell; W G Middleton; G J McHardy; M V Shotter; R McKenzie; A B Kay
Journal:  Thorax       Date:  1977-08       Impact factor: 9.139

3.  Rational intravenous doses of theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

4.  Clinical implications of drug-induced desensitization of the beta receptor after continuous oral use of terbutaline.

Authors:  W van den Berg; J G Leferink; J K Fokkens; J Kreukniet; R A Maes; P L Bruynzeel
Journal:  J Allergy Clin Immunol       Date:  1982-05       Impact factor: 10.793

5.  A comparison of histamine, methacholine, and exercise airway reactivity in normal and asthmatic subjects.

Authors:  M Chatham; E R Bleecker; P L Smith; R R Rosenthal; P Mason; P S Norman
Journal:  Am Rev Respir Dis       Date:  1982-08

6.  Effect of aerosol and oral fenoterol on histamine and methacholine challenge in asthmatic subjects.

Authors:  C M Salome; R E Schoeffel; A J Woolcock
Journal:  Thorax       Date:  1981-08       Impact factor: 9.139

Review 7.  Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance.

Authors:  F E Hargreave; G Ryan; N C Thomson; P M O'Byrne; K Latimer; E F Juniper; J Dolovich
Journal:  J Allergy Clin Immunol       Date:  1981-11       Impact factor: 10.793

8.  Terbutaline serum concentrations related to different lung function parameters and beta-receptor function.

Authors:  W van den Berg; J G Leferink; W Tabingh Suermondt; J Kreukniet; R A Maes; R Serra; P L Bruynzeel
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1983-01

9.  Protective effect of disodium cromoglycate on propranolol challenge.

Authors:  G H Koëter; H Meurs; J G de Monchy; K de Vries
Journal:  Allergy       Date:  1982-11       Impact factor: 13.146

10.  Asthma induced by cold air and its relation to nonspecific bronchial responsiveness to methacholine.

Authors:  P M O'Byrne; G Ryan; M Morris; D McCormack; N L Jones; J L Morse; F E Hargreave
Journal:  Am Rev Respir Dis       Date:  1982-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.